Skip to content

Effects of remimazolam on heart rate variability

Differential effects of propofol and remimazolam on heart rate variability during anesthetic induction - Differential effects of propofol and remimazolam on heart rate variability during anesthetic induction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043447
Enrollment
30
Registered
2021-03-01
Start date
2021-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients who receive general anesthesia

Interventions

Surgical patients were randomized to remimazolam started at 12 mg/kg/h by continuous intravenous (IV) infusion until the loss of consciousness (LoC), followed by 1 mg/kg/h to be adjusted as appropriat

Sponsors

Sapporo Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Relevant inclusion criteria included over 18 years old, a bodyweight of 100 kg or less, scheduled for elective surgery requiring tracheal intubation and an American Society of Anesthesiologists physical status of 1 or 2

Exclusion criteria

Exclusion criteria: Key exclusion criteria included emergency surgeries or patients with consciousness disturbance, drug dependence, alcohol dependence, uncontrolled hypertension, acute angle-closure glaucoma, myasthenia gravis, renal failure, massive hemorrhage, shock and pregnant and nursing women.

Design outcomes

Primary

MeasureTime frame
Changes in heart rate variability before and after anesthetic induction with propofol or remimazolam

Secondary

MeasureTime frame
Changes in blood pressure and heart rate before and after anesthetic induction with propofol for remimazolam

Countries

Japan

Contacts

Public ContactNaoyuki Hirata

Sapporo Medical University School of Medicine Department of Anesthesiology

naohirata@mac.com011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026